Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charter Communications Inc (CHTR) vs Stryker Corporation (SYK) Price & Performance

Charter Communications IncTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Charter Communications Inc vs Stryker Corporation — how do they compare? Charter Communications Inc trades at $157.44 (market cap $18.28B), while Stryker Corporation trades at $346.62 (market cap $132.64B). The key difference: Stryker Corporation is far larger — about 7.3× Charter Communications Inc's market cap, and Stryker Corporation pays a 1.02% dividend while Charter Communications Inc pays none. Which is the better fit depends on your goals.

CHTRSYK
Market Cap
$18.28B$132.64B
Sector
MediaTechnology
52-Week High
$282.74$394.34
52-Week Low
$123.31$282.58
Enterprise Value
$114.49B$144.11B
Dividend Yield
1.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charter Communications Inc

Charter Communications (CHTR) trades at $152.57, down 3.09% on the day, with a bullish technical signal from moving averages but mixed oscillators. The stock shows low valuation multiples with a P/E of 3.97 and P/S of 0.36, supported by a 9.05% net income margin and strong operating cash flow of $16.08B in 2025. Recent Q2 2026 earnings beat expectations with EPS of $10.66 versus $9.98 estimated, though revenue declined 1.7% year-over-year. News highlights debt refinancing activities and competitive pressures in broadband.

The outlook remains cautious due to subscriber losses and fiber competition, but the extreme valuation discount and aggressive buybacks offer potential upside. Risks include high debt leverage at $93.21B long-term and persistent industry headwinds. Analyst consensus is mixed with a $166.18 price target, suggesting 9% upside from current levels.

Stryker Corporation

Stryker (SYK) trades at $339.03, up 0.47% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $3.69 versus $3.49 expected, and demonstrated robust 9% organic sales growth. Analyst consensus is strongly positive with a $379.44 price target and 74% buy ratings. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS robotic technology.

The outlook remains favorable given earnings momentum and product innovation, though risks include competitive pressures and potential cyber disruptions. Valuation multiples such as a P/E of 35.84 suggest premium pricing, requiring sustained growth to justify. Institutional ownership trends show mixed activity, with some funds increasing stakes recently.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charter Communications Inc

Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 54 million U.S. homes and businesses, around 40% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest U.S. cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.

Read more on CHTR

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK